Tsuyoshi Osawa

2.5k total citations
37 papers, 1.4k citations indexed

About

Tsuyoshi Osawa is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Tsuyoshi Osawa has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Tsuyoshi Osawa's work include Cancer, Hypoxia, and Metabolism (14 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Tsuyoshi Osawa is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Epigenetics and DNA Methylation (6 papers) and RNA modifications and cancer (6 papers). Tsuyoshi Osawa collaborates with scholars based in Japan, United States and Australia. Tsuyoshi Osawa's co-authors include Masabumi Shibuya, Masashi Muramatsu, Tatsuhiko Kodama, Hiroyuki Aburatani, Takashi Minami, Rika Tsuchida, Juro Sakai, Teppei Shimamura, Shogo Yamamoto and Yasuharu Kanki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Tsuyoshi Osawa

36 papers receiving 1.4k citations

Peers

Tsuyoshi Osawa
Nilgun Tasdemir United States
Jorge A. Almenara United States
Victor Stastny United States
Yong Chuan Wong Hong Kong
Marcus Bosenberg United States
Nilgun Tasdemir United States
Tsuyoshi Osawa
Citations per year, relative to Tsuyoshi Osawa Tsuyoshi Osawa (= 1×) peers Nilgun Tasdemir

Countries citing papers authored by Tsuyoshi Osawa

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Osawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Osawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Osawa more than expected).

Fields of papers citing papers by Tsuyoshi Osawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Osawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Osawa. The network helps show where Tsuyoshi Osawa may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Osawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Osawa. A scholar is included among the top collaborators of Tsuyoshi Osawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Osawa. Tsuyoshi Osawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Satoh, Yusuke, Ryodai Yamamura, Takako Ooshio, et al.. (2025). Inhibition of NAD-GPx4 axis and MEK triggers ferroptosis to suppress pancreatic ductal adenocarcinoma. Molecular Therapy. 33(9). 4618–4635.
2.
Yoneshiro, Takeshi, Mami Matsushita, Yuko Kurosawa, et al.. (2025). Pre-fertilization-origin preservation of brown fat-mediated energy expenditure in humans. Nature Metabolism. 7(4). 778–791. 4 indexed citations
3.
Aki, Sho, Ryuichi Nakahara, Keisuke Maeda, & Tsuyoshi Osawa. (2023). Cancer metabolism within tumor microenvironments. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(5). 130330–130330. 21 indexed citations
4.
Kato, Miki, Keisuke Maeda, Ryuichi Nakahara, et al.. (2023). Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophils. PNAS Nexus. 2(10). pgad306–pgad306. 7 indexed citations
5.
Nakahara, Ryuichi, Keisuke Maeda, Sho Aki, & Tsuyoshi Osawa. (2023). Metabolic adaptations of cancer in extreme tumor microenvironments. Cancer Science. 114(4). 1200–1207. 19 indexed citations
6.
Waku, Tsuyoshi, Keiko Endo, Atsushi Hatanaka, et al.. (2023). NRF3 activates mTORC1 arginine-dependently for cancer cell viability. iScience. 26(2). 106045–106045. 7 indexed citations
7.
Kaneko, Yudai, Kenzo Yamatsugu, Takefumi Yamashita, et al.. (2022). Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment. Cancer Science. 113(12). 4350–4362. 2 indexed citations
8.
Zorbas, Christiane, Kensuke Ishiguro, Miki Kato, et al.. (2022). Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors. Nature Communications. 13(1). 3706–3706. 15 indexed citations
9.
Yamatsugu, Kenzo, Hiroto Katoh, Takefumi Yamashita, et al.. (2021). Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system. Protein Expression and Purification. 192. 106043–106043. 4 indexed citations
10.
Muramatsu, Masashi, Tsuyoshi Osawa, Suguru Nakagawa, et al.. (2021). Loss of Down syndrome critical region-1 leads to cholesterol metabolic dysfunction that exaggerates hypercholesterolemia in ApoE-null background. Journal of Biological Chemistry. 296. 100697–100697. 5 indexed citations
11.
Yoneshiro, Takeshi, Naoya Kataoka, Jacquelyn M. Walejko, et al.. (2021). Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever. eLife. 10. 25 indexed citations
12.
Sasaki, Yusuke, Toshiya Tanaka, Shogo Yamamoto, et al.. (2020). Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content. Scientific Reports. 10(1). 7818–7818. 77 indexed citations
13.
Kidoya, Hiroyasu, Fumitaka Muramatsu, Teppei Shimamura, et al.. (2019). Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis. Nature Communications. 10(1). 1072–1072. 23 indexed citations
14.
Kanki, Yasuharu, Ryo Nakaki, Teppei Shimamura, et al.. (2017). Dynamically and epigenetically coordinated GATA/ETS/SOX transcription factor expression is indispensable for endothelial cell differentiation. Nucleic Acids Research. 45(8). 4344–4358. 42 indexed citations
15.
Kondo, Ayano & Tsuyoshi Osawa. (2017). Establishment of an Extracellular Acidic pH Culture System. Journal of Visualized Experiments. 7 indexed citations
16.
Osawa, Tsuyoshi, Rika Tsuchida, Masashi Muramatsu, et al.. (2013). Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages. Cancer Research. 73(10). 3019–3028. 72 indexed citations
17.
Méndez‐Barbero, Nerea, Vanesa Esteban, Amelia Escolano, et al.. (2013). A major role for RCAN 1 in atherosclerosis progression. EMBO Molecular Medicine. 5(12). 1901–1917. 33 indexed citations
18.
Yae, Toshifumi, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.. (2012). Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nature Communications. 3(1). 883–883. 311 indexed citations
20.
Muramatsu, Masashi, Seiji Yamamoto, Tsuyoshi Osawa, & Masabumi Shibuya. (2010). Vascular Endothelial Growth Factor Receptor-1 Signaling Promotes Mobilization of Macrophage Lineage Cells from Bone Marrow and Stimulates Solid Tumor Growth. Cancer Research. 70(20). 8211–8221. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026